GlassScriptPhysician profile
Cadence Kim
NPI 1902809304
$2,682.91
in general payments reported to CMS, 2019-2025
21 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $351 · 2021: $438 · 2022: $294 · 2023: $387 · 2024: $459 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.75 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,076.68 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $178.57 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $167.90 | 2019-2023 | Erleada |
| 180 Medical, INC. | $162.60 | 2019-2024 | |
| Dentsply Ih Ab | $155.02 | 2023-2025 | Lofric, Lofric |
| Pfizer INC. | $142.13 | 2019-2025 | |
| Abbvie INC. | $122.97 | 2019-2021 | |
| Myovant Sciences INC. | $117.63 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $111.10 | 2022-2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $88.01 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $71.18 | 2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $61.75 | 2019-2020 | |
| Telix Pharmaceuticals | $47.50 | 2023 | Illuccix |
| Urogen Pharma, INC. | $38.71 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $27.27 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $24.08 | 2020 | |
| Neotract INC. | $23.00 | 2020 | |
| Convatec INC. | $20.66 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.45 | 2021 | |
| Avation Medical, INC. | $16.84 | 2025 | Vivally System |
| Aytu Biopharma, INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cadence Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.